机构

• 上海药物研究所 [16]
• 沈阳应用生态研究所 [8]
• 合肥物质科学研究院 [8]
• 高能物理研究所 [3]
• 计算技术研究所 [2]
• 力学研究所 [1]
• 更多

采集方式

• OAI收割 [42]
• iSwitch采集 [3]

内容类型

• 期刊论文 [43]
• 学位论文 [2]

发表日期

• 2024 [1]
• 2023 [4]
• 2022 [5]
• 2021 [4]
• 2020 [2]
• 2019 [1]
• 更多

学科主题

• Chemistry,... [1]
• Oncology; ... [1]
• Pharmacolo... [1]
• Plant Scie... [1]

筛选

浏览/检索结果: 共45条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：59/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   A Simple and Low-cost Preliminary Quantification of Target Membrane Protein in Single Cells 期刊论文  OAI收割 JOURNAL OF FLUORESCENCE, 2023, 页码: 8 作者:  Li, Jiamin;  Shi, Meng;  Geng, Xuhui;  Guan, Yafeng   |  收藏  |  浏览/下载：16/0  |  提交时间：2023/12/25 Single cell  Membrane Proteins  Capillary Electrophoresis  Fluorescence  HER2 Protein   Synthesis, and biological evaluation of EGFR/HER2-NAMPT conjugates for tumor treatment 期刊论文  OAI收割 MOLECULAR DIVERSITY, 2023, 页码: 20 作者:  Ding, Mengyuan;  Shen, Qianqian;  Lu, Wei;  Zhu, Shulei   |  收藏  |  浏览/下载：100/0  |  提交时间：2023/10/17 EGFR  HER2  NAMPT  Resistance  Selectivity  Molecular docking   Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor 期刊论文  OAI收割 MOLECULAR PHARMACEUTICS, 2023, 卷号: 20, 期号: 2, 页码: 1394-1403 作者:  Cao, Rui;  Li, Renda;  Shi, Hui;  Liu, Hongguang;  Cheng, Zhen   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/03/27 NIR-II  peptide  HER2  tumor  optical imaging   Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning 期刊论文  OAI收割 DIAGNOSTICS, 2023, 卷号: 13, 期号: 2, 页码: 14 作者:  Che, Yuxuan;  Ren, Fei;  Zhang, Xueyuan;  Cui, Li;  Wu, Huanwen   |  收藏  |  浏览/下载：22/0  |  提交时间：2023/07/12 breast cancer  HER2  IHC  whole-slide image  deep learning   Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13 作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang   |  收藏  |  浏览/下载：34/0  |  提交时间：2022/12/22 HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies   The Dual-Targeted Peptide Conjugated Probe for Depicting Residual Nasopharyngeal Carcinoma and Guiding Surgery 期刊论文  OAI收割 BIOSENSORS-BASEL, 2022, 卷号: 12, 期号: 9, 页码: 14 作者:  Huang, Wenhui;  He, Zicong;  Cai, Xuekang;  Zhang, Jingming;  Li, Wei   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/11/14 nasopharyngeal carcinoma  HER2  SR-BI  optoacoustic imaging  fluorescence molecular imaging  imaging-guided surgery   Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Jiang, Chuner;  Wu, Peng;  He, Xiangming;  Ni, Jianfen;  Ding, Xiaowen   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23 breast cancer  postmenopausal  reproductive hormones  estrogen receptor  progesterone receptor  HER2 receptor   HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib 期刊论文  OAI收割 ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11 作者:  Fan, Ying;  Qin, Jing;  Han, Na;  Lu, Hongyang   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/23 Leptomeningeal metastasis (LM)  cerebrospinal fluid  HER2 exon 20 insertion mutations  poziotinib  case report   CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang   |  收藏  |  浏览/下载：69/0  |  提交时间：2022/03/28 HER2  breast cancers  gastric cancers  irreversible inhibitor  drug resistance